Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study

Qiutang Xiong, Ming Xu, Jiao Li, Yinghui Liu, Jixiang Zhang, Yu Xu, Weiguo Dong, Qiutang Xiong, Ming Xu, Jiao Li, Yinghui Liu, Jixiang Zhang, Yu Xu, Weiguo Dong

Abstract

Objectives: To describe the prevalence, nature and risk factors for the main clinical sequelae in coronavirus disease 2019 (COVID-19) survivors who have been discharged from the hospital for more than 3 months.

Methods: This longitudinal study was based on a telephone follow-up survey of COVID-19 patients hospitalized and discharged from Renmin Hospital of Wuhan University, Wuhan, China before 1 March 2020. Demographic and clinical characteristics and self-reported clinical sequelae of the survivors were described and analysed. A cohort of volunteers who were free of COVID-19 and lived in the urban area of Wuhan during the outbreak were also selected as the comparison group.

Results: Among 538 survivors (293, 54.5% female), the median (interquartile range) age was 52.0 (41.0-62.0) years, and the time from discharge from hospital to first follow-up was 97.0 (95.0-102.0) days. Clinical sequelae were common, including general symptoms (n = 267, 49.6%), respiratory symptoms (n = 210, 39%), cardiovascular-related symptoms (n = 70, 13%), psychosocial symptoms (n = 122, 22.7%) and alopecia (n = 154, 28.6%). We found that physical decline/fatigue (p < 0.01), postactivity polypnoea (p= 0.04) and alopecia (p < 0.01) were more common in female than in male subjects. Dyspnoea during hospitalization was associated with subsequent physical decline/fatigue, postactivity polypnoea and resting heart rate increases but not specifically with alopecia. A history of asthma during hospitalization was associated with subsequent postactivity polypnoea sequela. A history of pulse ≥90 bpm during hospitalization was associated with resting heart rate increase in convalescence. The duration of virus shedding after COVID-19 onset and hospital length of stay were longer in survivors with physical decline/fatigue or postactivity polypnoea than in those without.

Conclusions: Clinical sequelae during early COVID-19 convalescence were common; some of these sequelae might be related to gender, age and clinical characteristics during hospitalization.

Keywords: COVID-19; Clinical sequelae; Early recovery; SARS-CoV-2; Survivors.

Copyright © 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Figures

Fig. 1
Fig. 1
Study sample.

References

    1. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382:1199–1207.
    1. Demertzis Z.D., Dagher C., Malette K.M., Fadel R.A., Bradley P.B., Brar I. Cardiac sequelae of novel coronavirus disease 2019 (COVID-19): a clinical case series. Eur Heart J Case Rep. 2020
    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720.
    1. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069.
    1. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
    1. Chan K.S., Zheng J.P., Mok Y.W., Li Y.M., Liu Y.N., Chu C.M. SARS: prognosis, outcome and sequelae. Respirology. 2003;8:S36–S40.
    1. Lam M.H., Wing Y.K., Yu M.W., Leung C.M., Ma R.C., Kong A.P. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169:2142–2147.
    1. Antonio G.E., Wong K.T., Hui D.S., Wu A., Lee N., Yuen E.H. Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology. 2003;228:810–815.
    1. Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611–627.
    1. Carfì A., Bernabei R., Landi F. Gemelli against COVID-19 post–acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603–605.
    1. World Health Organization (WHO) WHO; Geneva: 2020. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, 28 January 2020. Available at:
    1. Mattia J.G., Vandy M.J., Chang J.C., Platt D.E., Dierberg K., Bausch D.G. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis. 2016;16:331–338.
    1. Chew N.W.S., Lee G.K.H., Tan B.Y.Q., Jing M., Goh Y., Ngiam N.J.H. A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak. Brain Behav Immun. 2020;88:559–565.
    1. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062.
    1. Wu C., Chen X., Cai Y., Xia Ja, Zhou X., Xu S. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934–943.
    1. Fried J.A., Ramasubbu K., Bhatt R., Topkara V.K., Clerkin K.J., Horn E. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141:1930–1936.
    1. Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802–810.
    1. Lai P.H., Lancet E.A., Weiden M.D., Webber M.P., Zeig-Owens R., Hall C.B. Characteristics associated with out-of-hospital cardiac arrests and resuscitations during the novel coronavirus disease 2019 pandemic in New York City. JAMA Cardiol. 2020
    1. Baldi E., Sechi G.M., Mare C., Canevari F., Brancaglione A., Primi R. Out-of-hospital cardiac arrest during the COVID-19 outbreak in Italy. N Engl J Med. 2020;383:496–498.
    1. South A.M., Diz D.I., Chappell M.C. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol. 2020;318:H1084–H1090.
    1. Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280. e278.
    1. Shanafelt T., Ripp J., Trockel M. Understanding and addressing sources of anxiety among health care professionals during the COVID-19 pandemic. JAMA. 2020;323:2133–2134.
    1. Dubey S., Biswas P., Ghosh R., Chatterjee S., Dubey M.J., Chatterjee S. Psychosocial impact of COVID-19. Diabetes Metab Syndr. 2020;14:779–788.
    1. McGinty E.E., Presskreischer R., Han H., Barry C.L. Psychological distress and loneliness reported by us adults in 2018 and april 2020. JAMA. 2020;324:93–94.
    1. Asmundson G.J.G., Taylor S. Coronaphobia: fear and the 2019-nCoV outbreak. J Anxiety Disord. 2020;70:102196.
    1. Brooks S.K., Webster R.K., Smith L.E., Woodland L., Wessely S., Greenberg N. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912–920.
    1. Greenberg N., Docherty M., Gnanapragasam S., Wessely S. Managing mental health challenges faced by healthcare workers during COVID-19 pandemic. BMJ. 2020;368:m1211.
    1. Chaves C., Castellanos T., Abrams M., Vazquez C. The impact of economic recessions on depression and individual and social well-being: the case of Spain (2006–2013) Soc Psychiatry Psychiatr Epidemiol. 2018;53:977–986.
    1. Saceda-Corralo D., Pindado-Ortega C., Moreno-Arrones O.M., Ortega-Quijano D., Fernández-Nieto D., Jiménez-Cauhe J. Association of inflammation with progression of hair loss in women with frontal fibrosing alopecia. JAMA Dermatol. 2020;156:700–702.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner